Tamer Tetıker

819 total citations
44 papers, 497 citations indexed

About

Tamer Tetıker is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Rehabilitation. According to data from OpenAlex, Tamer Tetıker has authored 44 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Surgery and 5 papers in Rehabilitation. Recurrent topics in Tamer Tetıker's work include Adrenal and Paraganglionic Tumors (13 papers), Pituitary Gland Disorders and Treatments (11 papers) and Hormonal Regulation and Hypertension (8 papers). Tamer Tetıker is often cited by papers focused on Adrenal and Paraganglionic Tumors (13 papers), Pituitary Gland Disorders and Treatments (11 papers) and Hormonal Regulation and Hypertension (8 papers). Tamer Tetıker collaborates with scholars based in Türkiye, United States and Russia. Tamer Tetıker's co-authors include Murat Sert, Sinan Kırım, Gamze Akkuş, Mustafa Koçak, Hüseyin Bayram, Derya Gümürdülü, M.F. Karakaş, Yeşim Taşova, Levent Soylu and Canan Ersöz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Atherosclerosis and Clinical Microbiology and Infection.

In The Last Decade

Tamer Tetıker

41 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tamer Tetıker Türkiye 13 298 166 74 66 61 44 497
Pietro Gallotti Italy 14 205 0.7× 109 0.7× 76 1.0× 79 1.2× 67 1.1× 31 590
T. Evans United Kingdom 9 236 0.8× 137 0.8× 52 0.7× 39 0.6× 173 2.8× 14 607
Yuqing Wang China 10 95 0.3× 81 0.5× 54 0.7× 55 0.8× 32 0.5× 31 382
Lorenzo Alviggi Italy 17 250 0.8× 182 1.1× 42 0.6× 68 1.0× 57 0.9× 22 724
Laura Răducu Romania 11 55 0.2× 100 0.6× 31 0.4× 39 0.6× 18 0.3× 68 287
Adrian Pendleton United Kingdom 9 96 0.3× 270 1.6× 63 0.9× 85 1.3× 25 0.4× 18 631
Robert Steffner United States 13 42 0.1× 182 1.1× 51 0.7× 88 1.3× 31 0.5× 30 472
Jim Iliopoulos Australia 9 36 0.1× 129 0.8× 52 0.7× 42 0.6× 31 0.5× 25 458
Marjorie Risman United States 7 72 0.2× 111 0.7× 38 0.5× 34 0.5× 15 0.2× 9 366
Michel Rodier France 10 296 1.0× 195 1.2× 51 0.7× 35 0.5× 140 2.3× 12 565

Countries citing papers authored by Tamer Tetıker

Since Specialization
Citations

This map shows the geographic impact of Tamer Tetıker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamer Tetıker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamer Tetıker more than expected).

Fields of papers citing papers by Tamer Tetıker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamer Tetıker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamer Tetıker. The network helps show where Tamer Tetıker may publish in the future.

Co-authorship network of co-authors of Tamer Tetıker

This figure shows the co-authorship network connecting the top 25 collaborators of Tamer Tetıker. A scholar is included among the top collaborators of Tamer Tetıker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamer Tetıker. Tamer Tetıker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akkuş, Gamze, et al.. (2025). Clinical Outcomes of Patients with Adrenal Incidentaloma - Hypertension being a Continuous Risk Factor for the Presence of Comorbidity: A Single Center’s Eight-year Experience. Current Medical Imaging Formerly Current Medical Imaging Reviews. 21. e15734056347340–e15734056347340.
2.
3.
Akkuş, Gamze, et al.. (2021). Is it Possible to Assess the Functional Status of Hormone Secretion or Non-Secretion of Adrenal Masses Through Their Magnetic Resonance Imaging(MRI) Characteristics?. Endocrine Metabolic & Immune Disorders - Drug Targets. 22(6). 650–657. 1 indexed citations
4.
Akkuş, Gamze, et al.. (2021). Novel Classification of Acromegaly in Accordance with Immunohistochemical Subtypes: Is There Really a Clinical Relevance?. Hormone and Metabolic Research. 54(1). 37–41. 4 indexed citations
5.
Akkuş, Gamze, et al.. (2021). Pituitary Volume in Patients with Primary Empty Sella and Clinical Relevance to Pituitary Hormone Secretion: A Retrospective Single Center Study. Current Medical Imaging Formerly Current Medical Imaging Reviews. 17(8). 1018–1024. 4 indexed citations
6.
Akkuş, Gamze, et al.. (2020). Outcomes of surgical and/or medical treatment in patients with prolactinomas during long-term follow-up: a retrospective single-centre study. Hormone Molecular Biology and Clinical Investigation. 42(2). 153–157. 1 indexed citations
7.
Akkuş, Gamze, Nuri Eralp Çetinalp, Arbil Açıkalın, et al.. (2020). Clinical Relevance and Immunohistochemical Patterns of Silent Pituitary Adenomas: 10 Years of Single-centre Experience. Current Medical Imaging Formerly Current Medical Imaging Reviews. 17(2). 310–317. 1 indexed citations
8.
Akkuş, Gamze, Nuri Eralp Çetinalp, Arbil Açıkalın, et al.. (2020). Clinical, hormonal, radiological and morphological comparison of patients with clinically evident Cushing's disease and patients with silent corticotroph cell adenoma. SHILAP Revista de lepidopterología. 45(4). 1720–1732. 2 indexed citations
9.
Akkuş, Gamze, et al.. (2020). Possible role of the receptor of advanced glycation end products (RAGE) in the clinical course of prostate neoplasia in patients with and without type 2 diabetes mellitus. International Journal of Clinical Practice. 75(3). e13723–e13723. 7 indexed citations
10.
Bayram, Fahrı, Alper Sönmez, Cem Haymana, et al.. (2020). Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study). Lipids in Health and Disease. 19(1). 237–237. 8 indexed citations
11.
Akkuş, Gamze, et al.. (2018). Adipocytokines in Non-functional Adrenal Incidentalomas and Relation with Insulin Resistance Parameters. Endocrine Metabolic & Immune Disorders - Drug Targets. 19(3). 326–332. 14 indexed citations
12.
Mert, Mustafa Kurthan, Mehmet Satar, Nazan Özbarlas, et al.. (2015). Troponin T and NT ProBNP Levels in Gestational, Type 1 and Type 2 Diabetic Mothers and Macrosomic Infants. Pediatric Cardiology. 37(1). 76–83. 9 indexed citations
13.
Sert, Murat, et al.. (2014). A Case of Hypophosphatemic Rickets with the Secondary Hyperparathyroidism. American Journal of Medical Case Reports. 2(8). 158–160.
14.
Duman, Berna Bozkurt, et al.. (2012). Capecitabine-Induced Hypertriglyceridemia and Hyperglycemia: Two Cases. Pharmacology. 90(3-4). 212–215. 13 indexed citations
15.
Tetıker, Tamer, et al.. (2010). Diabetic dyslipidemia is a well-known issue, but what about lipoprotein a levels in Type 2 diabetics?. 18(2). 81–87. 9 indexed citations
16.
Sert, Murat, et al.. (2009). Review of Two Siblings with Werner's Syndrome: A Case Report. Case Reports in Medicine. 2009. 1–3. 4 indexed citations
17.
Saltoğlu, Neşe, et al.. (2009). Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital. Clinical Microbiology and Infection. 16(8). 1252–1257. 49 indexed citations
18.
19.
Tetıker, Tamer, et al.. (1995). An unusual amebic localization on the right hip. Infection. 23(2). 124–125. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pietro Gallotti Breakdown of academic impact, for papers by T. Evans Breakdown of academic impact, for papers by Yuqing Wang Breakdown of academic impact, for papers by Lorenzo Alviggi Breakdown of academic impact, for papers by Laura Răducu Breakdown of academic impact, for papers by Adrian Pendleton Breakdown of academic impact, for papers by Robert Steffner Breakdown of academic impact, for papers by Jim Iliopoulos Breakdown of academic impact, for papers by Marjorie Risman Breakdown of academic impact, for papers by Michel Rodier
Rankless by CCL
2026